De Fino, Chiara
 Distribuzione geografica
Continente #
NA - Nord America 940
EU - Europa 866
AS - Asia 274
AF - Africa 12
SA - Sud America 5
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 2.103
Nazione #
US - Stati Uniti d'America 940
DE - Germania 329
SE - Svezia 219
CN - Cina 120
IT - Italia 69
SG - Singapore 67
IE - Irlanda 50
FR - Francia 48
UA - Ucraina 47
GB - Regno Unito 36
ID - Indonesia 35
RU - Federazione Russa 25
IN - India 24
FI - Finlandia 17
CI - Costa d'Avorio 9
VN - Vietnam 9
BE - Belgio 6
JP - Giappone 5
TR - Turchia 5
CL - Cile 4
IL - Israele 4
A2 - ???statistics.table.value.countryCode.A2??? 3
IR - Iran 3
PL - Polonia 3
AT - Austria 2
AU - Australia 2
CZ - Repubblica Ceca 2
MD - Moldavia 2
NL - Olanda 2
SK - Slovacchia (Repubblica Slovacca) 2
BG - Bulgaria 1
BR - Brasile 1
CH - Svizzera 1
EG - Egitto 1
HU - Ungheria 1
KE - Kenya 1
KZ - Kazakistan 1
LI - Liechtenstein 1
MK - Macedonia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
RO - Romania 1
TN - Tunisia 1
Totale 2.103
Città #
Chandler 313
Ashburn 62
Dublin 50
Singapore 41
San Mateo 38
Wilmington 37
Jacksonville 35
Jakarta 35
Nürnberg 31
Beijing 29
New York 26
Nanjing 23
Boston 22
Milan 20
Princeton 19
Ann Arbor 18
Moscow 18
Cattolica 14
Nanchang 14
Dearborn 13
Norwalk 13
Lawrence 12
Los Angeles 12
Marseille 10
Abidjan 9
Hanoi 9
Bremen 8
Falls Church 8
Hebei 8
Woodbridge 8
Chicago 7
Houston 7
Rome 7
Brussels 6
Mountain View 6
Munich 6
Pune 6
Shanghai 6
Fairfield 5
Helsinki 5
Izmir 5
Lviv 5
Andover 4
Coquimbo 4
Fremont 4
Leawood 4
Mumbai 4
Redwood City 4
Seattle 4
Augusta 3
Changchun 3
Edinburgh 3
Fairport 3
Florence 3
Fuzhou 3
Jiaxing 3
Kunming 3
Lancaster 3
Amsterdam 2
Atlanta 2
Boardman 2
Buffalo 2
Changsha 2
Chengdu 2
Chiavari 2
Chisinau 2
Chiswick 2
Clearwater 2
Frankfurt am Main 2
Gunzenhausen 2
Lodz 2
Saint Louis 2
Shenyang 2
Tappahannock 2
Tehran 2
Almaty 1
Asciano 1
Auckland 1
Bangalore 1
Berlin 1
Brno 1
Budapest 1
Busto Arsizio 1
Cagliari 1
Cairo 1
Cormeilles-en-Parisis 1
Costa Mesa 1
Dallas 1
Duncan 1
Easton 1
Eden Prairie 1
Forest City 1
Fukuoka 1
Guangzhou 1
Haifa 1
Hangzhou 1
Hounslow 1
Jerusalem 1
Kathmandu 1
Kemerovo 1
Totale 1.140
Nome #
Second-Line Therapy with Fingolimod for Relapsing-Remitting Multiple Sclerosis in Clinical Practice: The Effect of Previous Exposure to Natalizumab 194
Second-Line Therapy with Fingolimod for Relapsing-Remitting Multiple Sclerosis in Clinical Practice: The Effect of Previous Exposure to Natalizumab 147
Sleep Disordered Breathing in a cohort of patients with sporadic Inclusion Body Myositis. 114
Idiopathic inflammatory myopathies evaluated by near infrared spectroscopy 100
Intravascular large B-cell lymphoma presenting as slowly progressive paraparesis with normal MRI features 98
Alemtuzumab-induced lung injury in multiple sclerosis: Learning from adversity in three patients 75
Depression in multiple sclerosis: effect of brain derived neurotrophic factor Val66Met polymorphism and disease perception 73
An atypical case of acute disseminated encephalomyelitis associated with cytomegalovirus infection 71
Disease Reactivation after Fingolimod Discontinuation in Pregnant Multiple Sclerosis Patients 67
Alemtuzumab-induced lung injury in multiple sclerosis: Learning from adversity in three patients 66
Defining the disease course of TNFα blockers-associated Multiple Sclerosis 64
Expression Profile of Long Non-Coding RNAs in Serum of Patients with Multiple Sclerosis. 63
Magnetic resonance imaging pattern recognition in sporadic Inclusion-Body Myositis 62
Correction: BDNF rs6265 polymorphism methylation in Multiple Sclerosis: A possible marker of disease progression(PLoS ONE (2018) 1310 (e0206140) DOI: 10.1371/journal.pone.0206140) 58
A pilot study of lncRNAs expression profile in serum of progressive multiple sclerosis patients 57
Focal muscle vibration, an effective rehabilitative approach in severe gait impairment due to multiple sclerosis 55
BDNF rs6265 polymorphism methylation in Multiple Sclerosis: A possible marker of disease progression 55
The predictive value of CSF multiple assay in multiple sclerosis: A single center experience 54
Severe dyspnoea with alteration of the diffusion capacity of the lung associated with fingolimod treatment 52
A unique case of multiphasic ADEM or what else? 52
Exit strategies for “needle fatigue” in multiple sclerosis: a propensity score-matched comparison study 51
The Prevalence of Multiple Sclerosis in the Metropolitan Area of Rome: A Capture-Recapture Analysis 50
Identifying Relapses in Multiple Sclerosis Patients through Administrative Data: A Validation Study in the Lazio Region, Italy 48
Sativex® effects on promoter methylation and on CNR1/CNR2 expression in peripheral blood mononuclear cells of progressive multiple sclerosis patients 48
Liver injury after pulsed methylprednisolone therapy in multiple sclerosis patients 48
Safety and Efficacy of Dimethyl Fumarate in Multiple Sclerosis: An Italian, Multicenter, Real-World Study 48
Anti-cN1A Antibodies Are Associated with More Severe Dysphagia in Sporadic Inclusion Body Myositis 46
The Expanding Role of the Infectious Disease Expert in the Context of the MS Centre 46
A pilot study of lncRNAs expression profile in serum of progressive multiple sclerosis patients 44
Is serological response to SARS-CoV-2 preserved in MS patients on ocrelizumab treatment? A case report 39
Delayed hypersensitivity to dimethyl fumarate: Report of 1 case and literature review 31
Transient hair loss during treatment with dimethyl-fumarate for multiple sclerosis 26
Neurosarcoidosis presenting as longitudinally extensive myelitis: Diagnostic assessment, differential diagnosis, and therapeutic approach 23
CSF CXCL13 and Chitinase 3-like-1 Levels Predict Disease Course in Relapsing Multiple Sclerosis 22
The predictive value of CSF multiple assay in multiple sclerosis: A single center experience 14
Totale 2.161
Categoria #
all - tutte 9.892
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.892


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020185 0 0 10 13 11 24 18 13 17 22 42 15
2020/2021117 10 11 1 9 8 7 8 4 13 8 31 7
2021/2022321 30 6 4 42 12 13 0 50 18 20 46 80
2022/2023730 97 111 65 121 41 87 29 58 70 10 27 14
2023/2024270 18 74 7 7 10 33 20 9 7 10 29 46
2024/202592 19 23 50 0 0 0 0 0 0 0 0 0
Totale 2.161